Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
68.35
-0.31 (-0.45%)
At close: Oct 30, 2026, 4:00 PM EDT
67.71
-0.64 (-0.94%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Sol-Gel Technologies Employees
Sol-Gel Technologies had 28 employees as of December 31, 2025. The number of employees decreased by 6 or 17.65% compared to the previous year. That makes Sol-Gel Technologies the 37,442nd largest employer in the world and 5,249th in the United States.
Employees
28
Change (1Y)
-6
Growth (1Y)
-17.65%
Revenue / Employee
$64,107
Profits / Employee
-$583,464
Market Cap
223.78M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 28 | -6 | -17.65% |
| Dec 31, 2024 | 34 | -2 | -5.56% |
| Dec 31, 2023 | 36 | -19 | -34.55% |
| Dec 31, 2022 | 55 | 2 | 3.77% |
| Dec 31, 2021 | 53 | -12 | -18.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| AC Immune | 122 |
| Artiva Biotherapeutics | 115 |
| Keros Therapeutics | 92 |
| BridgeBio Oncology Therapeutics | 88 |
| Precision BioSciences | 67 |
| Pyxis Oncology | 56 |
| Camp4 Therapeutics | 48 |
SLGL News
- 17 days ago - Sol-Gel Technologies Transcript: KOL event - Transcripts
- 17 days ago - Sol-Gel Technologies Slides: KOL event - Filings
- 17 days ago - Sol-Gel Technologies initiated with an Overweight at Cantor Fitzgerald - TheFly
- 17 days ago - Sol-Gel Technologies initiated with an Overweight at Cantor Fitzgerald - TheFly
- 4 weeks ago - Sol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026 - GlobeNewsWire
- 6 weeks ago - Sol-Gel Technologies announces last patient visit in SGT-610 trial - TheFly
- 6 weeks ago - Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome - GlobeNewsWire
- 2 months ago - Sol-Gel Technologies Earnings release: Q2 2026 - Filings